Tyra Biosciences, Inc. — Director's Dealing 2021

Sep 15, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tyra Biosciences, Inc. (TYRA)
CIK: 0001863127
Period of Report: 2021-09-14

Reporting Person: KAPLAN GILLA (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	28231	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.61	2030-01-26	Common Stock (61392)		Direct
Stock Option (Right to Buy)	$2.25	2031-03-09	Common Stock (67467)		Direct

Footnotes

F1: 25% of the shares subject to the option will vest on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.

F2: 1/36th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.